melatonin has been researched along with Adenocarcinoma Of Kidney in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin was given orally at 20 mg/day in the evening for at least 2 months." | 2.70 | Anti-angiogenic activity of melatonin in advanced cancer patients. ( Bucovec, R; Conti, A; Lissoni, P; Maestroni, GJ; Malugani, F; Rovelli, F, 2001) |
| "Metabolic alteration drives renal cell carcinoma (RCC) development, while the impact of melatonin (MLT), a neurohormone secreted during darkness, on RCC cell growth and underlying mechanisms remains unclear." | 1.91 | Melatonin suppresses Akt/mTOR/S6K activity, induces cell apoptosis, and synergistically inhibits cell growth with sunitinib in renal carcinoma cells via reversing Warburg effect. ( Bai, JY; Chen, YH; Guo, P; Jiang, YF; Ma, JB; Wang, X; Xue, KH; Zhang, DZ; Zhu, ZJ, 2023) |
| "The study was performed on metastatic renal cell cancer patients." | 1.30 | Immunomodulatory effects of IL-12 in relation to the pineal endocrine function in metastatic cancer patients. ( Fumagalli, L; Giani, L; Lissoni, P; Mandalà, M; Rovelli, F, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, A | 1 |
| Cai, C | 1 |
| Yang, Y | 1 |
| Cui, Y | 1 |
| Liu, W | 1 |
| Pang, Q | 1 |
| Wu, Z | 1 |
| Liu, B | 1 |
| Qu, L | 1 |
| Luo, P | 1 |
| Wang, A | 1 |
| Wang, L | 1 |
| Xue, KH | 1 |
| Jiang, YF | 1 |
| Bai, JY | 1 |
| Zhang, DZ | 1 |
| Chen, YH | 1 |
| Ma, JB | 1 |
| Zhu, ZJ | 1 |
| Wang, X | 1 |
| Guo, P | 1 |
| Wen, YC | 1 |
| Lin, YW | 2 |
| Chu, CY | 2 |
| Yang, YC | 2 |
| Yang, SF | 2 |
| Liu, YF | 1 |
| Hsiao, M | 2 |
| Lee, WJ | 2 |
| Chien, MH | 2 |
| Lee, LM | 1 |
| Tan, P | 1 |
| Chen, WY | 1 |
| Lissoni, P | 4 |
| Malugani, F | 2 |
| Malysheva, O | 1 |
| Kozlov, V | 1 |
| Laudon, M | 1 |
| Conti, A | 2 |
| Maestroni, G | 1 |
| Song, Y | 1 |
| Tam, PC | 1 |
| Poon, AM | 1 |
| Brown, GM | 1 |
| Pang, SF | 1 |
| Neri, B | 1 |
| Fiorelli, C | 1 |
| Moroni, F | 1 |
| Nicita, G | 1 |
| Paoletti, MC | 1 |
| Ponchietti, R | 1 |
| Raugei, A | 1 |
| Santoni, G | 1 |
| Trippitelli, A | 1 |
| Grechi, G | 1 |
| Taverna, G | 1 |
| Trinchieri, A | 1 |
| Mandressi, A | 1 |
| Del Nero, A | 1 |
| Mangiarotti, B | 1 |
| Antonelli, D | 1 |
| Chisena, S | 1 |
| Pisani, E | 1 |
| Mandalà, M | 2 |
| Brivio, F | 1 |
| Rovelli, F | 2 |
| Giani, L | 1 |
| Fumagalli, L | 1 |
| Bucovec, R | 1 |
| Maestroni, GJ | 1 |
4 trials available for melatonin and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system.
Topics: Adjuvants, Immunologic; Aged; Antineoplastic Agents; Carcinoma, Neuroendocrine; Carcinoma, Renal Cel | 2002 |
Modulation of human lymphoblastoid interferon activity by melatonin in metastatic renal cell carcinoma. A phase II study.
Topics: Adult; Aged; Carcinoma, Renal Cell; Female; Humans; Interferon-alpha; Kidney Neoplasms; Male; Melato | 1994 |
Abrogation of the negative influence of opioids on IL-2 immunotherapy of renal cell cancer by melatonin.
Topics: Adjuvants, Immunologic; Adult; Analgesics, Opioid; Carcinoma, Renal Cell; Female; Follow-Up Studies; | 2000 |
Anti-angiogenic activity of melatonin in advanced cancer patients.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; C | 2001 |
7 other studies available for melatonin and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Deciphering the Role of Melatonin-Related Signatures in Tumor Immunity and the Prognosis of Clear Cell Renal Cell Carcinoma.
Topics: Algorithms; Carcinoma, Renal Cell; DNA Copy Number Variations; Humans; Kidney Neoplasms; Melatonin; | 2023 |
Melatonin suppresses Akt/mTOR/S6K activity, induces cell apoptosis, and synergistically inhibits cell growth with sunitinib in renal carcinoma cells via reversing Warburg effect.
Topics: Antioxidants; Apoptosis; Carcinoma, Renal Cell; Chromatography, Liquid; Humans; Kidney Neoplasms; Me | 2023 |
Melatonin-triggered post-transcriptional and post-translational modifications of ADAMTS1 coordinately retard tumorigenesis and metastasis of renal cell carcinoma.
Topics: ADAMTS1 Protein; Animals; Carcinogenesis; Carcinoma, Renal Cell; Cell Line, Tumor; Humans; Kidney Ne | 2020 |
Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-κB DNA-binding activity.
Topics: Animals; Carcinoma, Renal Cell; DNA, Neoplasm; Gene Expression Regulation, Enzymologic; Gene Express | 2016 |
2-[125I]iodomelatonin-binding sites in the human kidney and the effect of guanosine 5'-O-(3-thiotriphosphate).
Topics: Adult; Aged; Autoradiography; Binding Sites; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Fe | 1995 |
Variation in nocturnal urinary excretion of melatonin in a group of patients older than 55 years suffering from urogenital tract disorders.
Topics: Aged; Aged, 80 and over; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Circadian Rhythm; Fema | 1997 |
Immunomodulatory effects of IL-12 in relation to the pineal endocrine function in metastatic cancer patients.
Topics: Adjuvants, Immunologic; Carcinoma, Renal Cell; Humans; Immunity, Innate; Immunotherapy; Inflammation | 1998 |